Page 22 - TD-2-1

Tumor Discovery Cancer progression in PCOS

menstrual cycle characteristics. Am J Epidemiol, of rosiglitazone and metformin on oxidative stress and
160(2): 131–140. homocysteine levels in lean patients with polycystic ovary
syndrome. Hum Reprod, 20(12): 3333–3340.
https://doi.org/10.1093/aje/kwh188
https://doi.org/10.1093/humrep/dei258
26. Rani R, Hajam YA, Kumar R, et al., 2022, A landscape
analysis of the potential role of polyphenols for the treatment 37. Moller DE, Flier JS, 1988, Detection of an alteration in the
of Polycystic Ovarian Syndrome (PCOS). Phytomed Plus, insulin-receptor gene in a patient with insulin resistance,
2(1): 100161. acanthosis nigricans, and the polycystic ovary syndrome
(Type A insulin resistance). N Engl J Med, 319(23): 1526–1529.
https://doi.org/10.1016/j.phyplu.2021.100161
https://doi.org/10.1056/NEJM198812083192306
27. Bulsara J, Patel P, Soni A, et al., 2021, A review: Brief insight
into polycystic ovarian syndrome. Endocrinol Metab Sci, 38. Diamanti-Kandarakis E, Papavassiliou AG, 2006, Molecular
3: 100085. mechanisms of insulin resistance in polycystic ovary
syndrome. Trends Mol Med, 12(7): 324–332.
https://doi.org/10.1016/j.endmts.2021.100085
https://doi.org/10.1016/j.molmed.2006.05.006
28. Ibáñez L, Oberfield SE, Witchel S, et al., 2017, An
international consortium update: Pathophysiology, 39. Burghen GA, Givens JR, Kitabchi AE, 1980, Correlation
diagnosis, and treatment of polycystic ovarian syndrome in of hyperandrogenism with hyperinsulinism in polycystic
adolescence. Horm Res Paediatr, 88(6): 371–395. ovarian disease. J Clin Endocrinol Metab, 50(1): 113–116.
https://doi.org/10.1159/000479371 https://doi.org/10.1210/jcem-50-1-113
29. Dumesic DA, Oberfield SE, Stener-Victorin E, et al., 2015, 40. Armanini D, Boscaro M, Bordin L, et al., 2022, Controversies
Scientific statement on the diagnostic criteria, epidemiology, in the pathogenesis, diagnosis and treatment of PCOS: Focus
pathophysiology, and molecular genetics of polycystic ovary on insulin resistance, inflammation, and hyperandrogenism.
syndrome. Endocr Rev, 36(5): 487–525. Int J Mol Sci, 23(8): 4110.
https://doi.org/10.1159/000479371 https://doi.org/10.3390/ijms23084110
30. Kanbour SA, Dobs AS, 2022, Hyperandrogenism in women 41. Willis D, Franks S, 1995, Insulin action in human granulosa
with polycystic ovarian syndrome: Pathophysiology and cells from normal and polycystic ovaries is mediated by
controversies. Androgens Clin Res Ther, 3(1): 22–30. the insulin receptor and not the Type-I insulin-like growth
factor receptor. J Clin Endocrinol Metab, 80(12): 3788–3790.
https://doi.org/10.1089/andro.2021.0020
https://doi.org/10.1210/jcem.80.12.8530637
31. Cheung AP, Cog F, 2010, Polycystic ovary syndrome:
A contemporary view. J Obstet Gynaecol Can, 32(5): 423–425. 42. Azziz R, Carmina E, Dewailly D, et al., 2009, The androgen
excess and PCOS society criteria for the polycystic ovary
https://doi.org/10.1016/S1701-2163(16)34493-0
syndrome: The complete task force report. Fertil Steril,
32. Walters KA, Gilchrist RB, Ledger WL, et al., 2018, New 91(2): 456–488.
perspectives on the pathogenesis of PCOS: Neuroendocrine https://doi.org/10.1016/j.fertnstert.2008.06.035
origins. Trends Endocrinol Metab, 29(12): 841–852.
43. Gambineri A, Patton L, Altieri P, et al., 2012, Polycystic ovary
https://doi.org/10.1016/j.tem.2018.08.005
syndrome is a risk factor for Type 2 diabetes: Results from a
33. Lv PP, Jin M, Rao JP, et al., 2020, Role of anti-Müllerian long-term prospective study. Diabetes, 61(9): 2369–2374.
hormone and testosterone in follicular growth: A cross- https://doi.org/10.2337/db11-1360
sectional study. BMC Endocr Disord, 20(1): 101.
44. Bremer AA, Miller WL, 2008, The serine phosphorylation
https://doi.org/10.1186/s12902-020-00569-6
hypothesis of polycystic ovary syndrome: A unifying
34. Ashraf S, Nabi M, Rashid F, et al., 2019, Hyperandrogenism mechanism for hyperandrogenemia and insulin resistance.
in polycystic ovarian syndrome and role of CYP gene Fertil Steril, 89(5): 1039–1048.
variants: A review. Egypt J Med Hum Genet, 20(1): 25.
https://doi.org/10.1016/j.fertnstert.2008.02.091
https://doi.org/10.1186/s43042-019-0031-4
45. Siddiqui S, Mateen S, Ahmad R, et al., 2022, A brief insight
35. Yau TT, Ng NY, Cheung LP, et al., 2017, Polycystic ovary into the etiology, genetics, and immunology of polycystic
syndrome: A common reproductive syndrome with ovarian syndrome (PCOS). J Assist Reprod Genet, 39(11):
long-term metabolic consequences. Hong Kong Med J, 2439–2473.
23(6): 622–634.
https://doi.org/10.1007/s10815-022-02625-7
https://doi.org/10.12809/hkmj176308
46. Moll GW Jr., Rosenfield RL, 1983, Plasma free testosterone
36. Yilmaz M, Bukan N, Ayvaz G, et al., 2005, The effects in the diagnosis of adolescent polycystic ovary syndrome.

Volume 2 Issue 1 (2023) 9 https://doi.org/10.36922/td.328